期刊文献+

右肺癌切除术后合并右侧胸腔侵袭性曲霉感染1例 被引量:1

下载PDF
导出
摘要 患者女性,65岁。渊右肺腺癌术后2年余,咳嗽、咳痰、发热20天余入院。患者闪体检发现打肺占位,于2009年5月21日在江苏省肿瘤医院行“右中下肺切除术+淋巴结清扫术”,术后病理显示“有肺低分化腺癌”,多组淋巴结均未见转移,术后未行辅助化疗。2009年11月,患者于江苏省中医院复查胸部CT显示“纵隔及右锁骨淋巴结肿大”,
出处 《临床肿瘤学杂志》 CAS 2013年第4期381-382,共2页 Chinese Clinical Oncology
关键词 肺癌 曲霉感染
  • 相关文献

参考文献4

  • 1朱小敏,周新.侵袭性肺曲霉病的诊断与治疗[J].中国呼吸与危重监护杂志,2005,4(4):316-320. 被引量:36
  • 2Ronen B, Russell E. Aspergillus fumigaliw inhibits angiogenesisthrough the production rtf gliotoxin and other secondary metabolites[J]. Blood, 2009, 114(26):5393-5399.
  • 3Delyth M, Neil A. Pattern recognition : recent insights from Deo-tin-1 [ J]. Curr Opin Immunol,2009,21(1):30-37.
  • 4Curtis R, Jing X. Inhibition of angiogenesis by ihe antifungaldrug itraconazole[ J]. ACS Chemical Biology,2007,2(4) :263 -270.

二级参考文献27

  • 1Becker M J, Lugtenburg E J, Cornelissen J J, et al. Galactomannan detection in computerized tomography-based broncho-alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis. Br J Haematol, 2003; 121:448 ~ 457
  • 2Wingard JR, White MH, Anaissie E, et al. A randomized, double-blind comparative trial evaluating the safety of liposomal amphoteric in B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. Clin Infect Dis, 2000;31:1155~ 1163
  • 3Takemoto K, Yamamoto Y, Ueda Y, et al. Comparative studies on the efficacy of AmBisome and fungizone in a mouse model of disseminated aspergillosis. J Antimicrob Chemother,2004;53:311 ~ 317
  • 4Caillot D. Intravenous itraconazole followed by oral itraconazole for the treatment of amphotericin-B-refractory invasive pulmonary aspergillosis. Acta Haematol, 2003; 109: 111 ~ 118
  • 5Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med ,2002;347:408 ~ 415
  • 6Yuet W. Voriconazole versue amphotericin for primary therapy of invasive aspergillosis. N Engl J Med, 2002; 347: 408 ~ 415
  • 7Petraitiene R, Petraitis V, Groll AH, et al. Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemia. Antimicrob Agents Chemother, 2001 ;45: 857 ~ 869
  • 8Taccone FS, Marechal R, Meuleman N, et al. Caspofungin salvage therapy in a neutropenic patient with probable invasive aspergillosis: a case report. Support Care Cancer, 2003; 11: 742 ~744
  • 9Lewis RE, Prince RA, Chi J, et al. Itraconazole preexposure attenuates the efficacy of subsequent amphotericin B therapy in a murine model of acute invasive pulmonary aspergillosis. Antimicrob Agents Chemother,2002;46:3208~ 3214
  • 10Popp AI, White MH, Quadri T, et al. Amphotericin B with and without itraconazole for invasive aspergillosis: a three-year retrospective study. Int J Infect Dis, 1999 ;3:157~ 160

共引文献35

同被引文献3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部